Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, Christer Nilsson, Jennifer L. Whitwell et al.|Movement Disorders|2017Cited by 2.3k
Four-repeat tauopathiesThomas W. Rösler, Günter U. Höglinger, Amir Tayaranian Marvian et al.|Progress in Neurobiology|2019Cited by 217
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger et al.|Movement Disorders|2017Cited by 163
Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1Axel Weber, Ulrich Müller|Nature Communications|2018Cited by 34
Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic componentUlrich Müller, Dennis W. Dickson|Acta Neuropathologica|2025Cited by 5